Iantrek

Glaucoma surgeons: what if you could avoid the post-MIGS efficacy cliff altogether? With AlloFlo™ Uveo Dual Bio-Spacers and the Allosert™ Uveo Delivery Platform — only from Iantrek — you can. Unlock the surgically underutilized uveoscleral pathway to enhance natural outflow Work with your patients’ natural physiology — while you stay in the angle. Minimize the risk of immune response and fibrosis YOUR POST-MIGS PATIENTS DESERVE ANOTHER OPTION to naturally enhance aqueous outflow.

Iantrek innovation unlocks the surgically underutilized uveoscleral pathway with a unique bio-interventional approach: • Allosert™ Uveo facilitates cyclodialysis cleft creation • Alloflo™ Uveo is used for bio-reinforcement of the cleft • Minimizes the risk of immune response and fibrosis YOUR POST-MIGS PATIENTS DESERVE MORE OPTIONS to naturally enhance aqueous outflow. Learn how to fill the treatment gap at iantrekmed.com.

Iantrek innovation unlocks the surgically underutilized uveoscleral pathway with a unique bio-interventional approach: • Allosert™ Uveo facilitates cyclodialysis cleft creation • Alloflo™ Uveo is used for bio-reinforcement of the cleft • Minimizes the risk of immune response and fibrosis Your post-MIGS patients deserve more options to naturally enhance aqueous outflow. Learn how to fill the treatment gap at iantrekmed.com.

When the efficacy of MIGS plateaus, higher-risk bleb-forming procedures have historically been the only remaining option. What if you could: • Delay the need for a bleb-forming procedure? • Surgically access a complementary, natural outflow path? • Add another surgical intervention to your toolkit? Now you can. Unlock a new surgical pathway to enhance natural outflow — with AlloFlo™ Uveo Dual Bio-Spacers and the Allosert™ Uveo Delivery Platform.

INTRODUCING ALLOFLO™ UVEO DUAL BIO-SPACERS AND THE ALLOSERT™ UVEO DELIVERY PLATFORM The first bio-interventional surgical approach to enhance natural outflow via the uveoscleral pathway — and fill the treatment gap for post-MIGS patients. When the efficacy of MIGS plateaus, higher-risk bleb-forming procedures have historically been the only remaining option. With Iantrek innovation, you can: • Delay the need for a bleb-forming procedure • Surgically access a complementary, natural outflow path • Add another surgical intervention to your toolkit

When the efficacy of MIGS plateaus, higher-risk bleb-forming procedures have historically been the only remaining option. WHAT IF YOU COULD: • Delay the need for a bleb-forming procedure? • Surgically access a complementary, natural outflow path? • Add another surgical intervention to your toolkit? NOW, YOU CAN. Unlock a new surgical pathway to enhance natural outflow — with AlloFlo™ Uveo Dual Bio-Spacers and the Allosert™ Uveo Delivery Platform.